Age, tympanogram may ID when to skip abx for acute otitis media

Age, tympanogram may ID when to skip abx for acute otitis media
(HealthDay)—For young children with acute otitis media (AOM), older age and peaked tympanogram at entry are associated with reduced risk of treatment failure, according to research published online Aug. 8 in Pediatrics.

Paula A. Tähtinen, M.D., Ph.D., from the Turku University Hospital in Finland, and colleagues conducted a secondary analysis of a randomized trial. A total of 319 children aged 6 to 35 months with AOM were randomized to receive seven days of amoxicillin-clavulanate or placebo.

The researchers found that 31.7 percent of all children had treatment failure. The risk for treatment failure was reduced for (24 to 35 months) and with peaked tympanogram at entry (hazard ratios, 0.53 and 0.43, respectively). Children with severe bulging of the tympanic membrane had the highest rate difference for between antimicrobial treatment and placebo groups (11.1 versus 64.1 percent; rate difference, −53.0 percent), resulting in a number needed to treat of 1.9.

"Children with severe bulging of the seem to benefit most from antimicrobial treatment of AOM," the authors write. "On the other hand, children with peaked tympanogram (A and C curves) may be optimal candidates for initial observation."


Explore further

Inhaled corticosteroids not linked to pneumonia in children

More information: Abstract/Full Text (subscription or payment may be required)
Journal information: Pediatrics

Copyright © 2017 HealthDay. All rights reserved.

Citation: Age, tympanogram may ID when to skip abx for acute otitis media (2017, August 9) retrieved 21 May 2019 from https://medicalxpress.com/news/2017-08-age-tympanogram-id-abx-acute.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more